Presentation
8 April 2024 Fluorescence-guided photoimmunotherapy for peritoneal carcinomatosis
Author Affiliations +
Abstract
Peritoneal metastasis, incomplete resection, and drug resistance render advanced-stage ovarian cancer virtually incurable with current surgical and chemotherapy approaches. Photoimmunotherapy is increasingly used to treat unresectable metastases, but many innovations are lost in translation due to heterogeneous treatment effects. This study integrates targeted nanotechnology, fluorescence-guided intervention, and a medical laser system to improve the safety, efficacy, and consistency of photoimmunotherapy for peritoneal metastases.
Conference Presentation
© (2024) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Barry Liang, Sumiao Pang, Robert Perttila, Chen-Hua Ma, Payal Srivastava, Brandon Gaitan, Aaron Sorrin, Nada Fadul, Idrisa Rahman, Zoe Ylöniemi, Dana Roque, Tayyaba Hasan, Petteri Uusimaa, and Huang-Chiao Huang "Fluorescence-guided photoimmunotherapy for peritoneal carcinomatosis", Proc. SPIE PC12823, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXXII, PC128230D (8 April 2024); https://doi.org/10.1117/12.3011885
Advertisement
Advertisement
KEYWORDS
Photoimmunotherapy

Chemotherapy

Mouse models

Photonic integrated circuits

Nanotechnology

Ovarian cancer

Photomedicine

Back to Top